415 related articles for article (PubMed ID: 18651827)
1. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
2. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of sporadic medullary thyroid cancer.
Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
[TBL] [Abstract][Full Text] [Related]
4. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
5. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
6. Medullary thyroid cancer with undetectable serum calcitonin.
Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
[TBL] [Abstract][Full Text] [Related]
7. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal.
Faggiano A; Milone F; Ramundo V; Chiofalo MG; Ventre I; Giannattasio R; Severino R; Lombardi G; Colao A; Pezzullo L
J Clin Endocrinol Metab; 2010 Sep; 95(9):E32-6. PubMed ID: 20534767
[TBL] [Abstract][Full Text] [Related]
8. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
10. [Calcitonin determination for early diagnosis of medullary thyroid cancer].
Karges W
Chirurg; 2010 Jul; 81(7):620, 622-6. PubMed ID: 20549176
[TBL] [Abstract][Full Text] [Related]
11. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
13. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
14. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
15. [Medullary thyroid cancer: review of 28 patients].
Pulgar B D; Jans B J; Petric G M; León R A; Camus A M; Goñi E I; Domínguez C F; Droppelmann M N; Claure S R; González D H
Rev Med Chil; 2013 Nov; 141(11):1395-401. PubMed ID: 24718465
[TBL] [Abstract][Full Text] [Related]
16. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.
Dora JM; Canalli MH; Capp C; Puñales MK; Vieira JG; Maia AL
Thyroid; 2008 Aug; 18(8):895-9. PubMed ID: 18651801
[TBL] [Abstract][Full Text] [Related]
17. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
18. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Gómez-Camarero P; Ortiz-de Tena A; Borrego-Dorado I; Vázquez-Albertino RJ; Navarro-González E; Ruiz-Franco-Baux JV; Cuenca-Cuenca JI
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):261-6. PubMed ID: 23067528
[TBL] [Abstract][Full Text] [Related]
20. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
